Study guide
5.2 Risk Assessment Tools & Risk Stratification
Certified Wound Specialist Physician CWSP
Track your progress as you read
Finished sections get a check mark.
1 Introduction
About the CWSP Exam
2 Chapter 1: Integumentary Anatomy & Wound Healing Biology
1.1 Skin Anatomy, Microstructure & Epidermal-Dermal Barrier Function 1.2 Acute vs Chronic Wound Healing Phases & Cellular Kinetics 1.3 Extracellular Matrix Composition, Collagen Architecture & MMP Regulation
3 Chapter 2: Musculoskeletal & Neurologic Anatomy
2.1 Musculoskeletal Anatomy of the Leg & Foot 2.2 Neuroanatomy & Nerve Physiology for Wound Care
4 Chapter 3: Cell Signaling, Biofilm & Barriers to Healing
3.1 Growth Factors, Cytokines & Angiogenic Pathways 3.2 Biofilm Microbiology, Quorum Sensing & Phenotypic Resistance 3.3 Cellular Senescence, Hypoxia & Inflammatory Arrest 3.4 Metabolic, Steroid & Nutritional Impairments in Wound Healing
5 Chapter 4: Patient Evaluation & Vascular Diagnostics
4.1 Comprehensive Patient & Periwound Physical Examination 4.2 Noninvasive Macrovascular Hemodynamics: ABI, TBI & Segmental Pressures 4.3 Microvascular Perfusion Diagnostics: TcPO2, SPP & Near-Infrared Spectroscopy 4.4 Diagnostic Angiography, Duplex Ultrasonography & Angiosome Concepts
6 Chapter 5: Pain, Risk, Functional & Nutrition Assessment
5.1 Wound Pain Assessment 5.2 Risk Assessment Tools & Risk Stratification 5.3 Functional & Cognitive Assessment 5.4 Nutrition Screening & Assessment
7 Chapter 6: Imaging, Biopsy, Atypical Wounds & Neuropathy
6.1 Musculoskeletal Imaging for Osteomyelitis & Deep Space Infections 6.2 Diagnostic Tissue Biopsy, Culture Techniques & Quantitative Microbiology 6.3 Diagnostic Differential of Atypical & Malignant Ulcerations 6.4 Comprehensive Diabetic Peripheral Neuropathy & Biomechanical Assessment
8 Chapter 7: Wound Bed Preparation, Debridement, Dressings & Topical Agents
7.1 TIME Principle & Wound Bed Preparation Framework 7.2 Surgical, Sharp, Enzymatic, Autolytic & Biosurgical Debridement Modalities 7.3 Advanced Wound Dressings, Exudate Control & Moisture Balance 7.4 Topical Agents: Antiseptics, Antibiotics & Active Topicals
9 Chapter 8: Cellular & Tissue-Based Products, NPWT & Hyperbaric Oxygen
8.1 Cellular, Acellular & Matrix-Like Advanced Biologics (CTPs) 8.2 Negative Pressure Wound Therapy (NPWT) & Instillation Protocols 8.3 Hyperbaric Oxygen Therapy (HBOT): Mechanisms, Indications & Safety
10 Chapter 9: Biophysical Technologies: Electrical Stimulation & Ultrasound
9.1 Electrical Stimulation for Wound Healing 9.2 Therapeutic Ultrasound in Wound Care
11 Chapter 10: Revascularization, Antimicrobial Stewardship & Offloading
10.1 Revascularization for Limb Salvage 10.2 Systemic Antimicrobial Stewardship & Deep Infection Management 10.3 Mechanical Offloading, Pressure Redistribution & Total Contact Casting
12 Chapter 11: Surgical Closure & Healing Complications
11.1 Surgical Closure, Skin Grafts, Flaps & Amputation Levels 11.2 Managing Complications: Bleeding, Allergy, Adverse Events & Scarring
13 Chapter 12: Nutrition Therapy & Case Review
12.1 Nutrition Therapy for Wound Healing 12.2 Case Review: Synthesizing Data, Outliers & Prognosis
14 Chapter 13: Diabetic & Ischemic Lower-Extremity Wounds
13.1 Diabetic Foot Ulcers: Pathophysiology, Staging & Limb Salvage 13.2 Peripheral Arterial Disease & Ischemic Extremity Ulcerations 13.3 Mixed Arterial-Venous Disease & Complex Diagnostic Dilemmas
15 Chapter 14: Venous Disease, Pressure Injuries, Lymphedema & Edema
14.1 Venous Leg Ulcers, Chronic Venous Insufficiency & Compression 14.2 Pressure Injuries: NPIAP Staging, DTPI & Prevention 14.3 Lymphedema, Phlebolymphedema & Complete Decongestive Therapy 14.4 Edema: Systemic vs. Local Causes
16 Chapter 15: Inflammatory, Calcific, Medication-Induced & Dermatologic Wounds
15.1 Autoimmune & Inflammatory Ulcerations: Pyoderma Gangrenosum & Vasculitis 15.2 Calciphylaxis & Radiation Tissue Injury 15.3 Medication-Induced & Hematologic Atypical Wounds 15.4 Dermatologic Conditions That Cause or Complicate Wounds
17 Chapter 16: Traumatic Wounds, Burns & Frostbite
16.1 Traumatic Wounds: Lacerations, Bites, Degloving & Open Fractures 16.2 Thermal Burns & Frostbite
18 Chapter 17: Surgical, Infectious & Pediatric Wounds
17.1 Surgical Wounds, Surgical Site Infection & Dehiscence 17.2 Infectious Causes of Wounds: Necrotizing, Mycobacterial, Fungal & Other Infections 17.3 Pediatric Wound Care
19 Chapter 18: Reimbursement, Regulation & Documentation
18.1 CPT Coding, Modifiers & Documentation for Debridement and Biologics 18.2 Regulatory Compliance, CMS Quality Programs & Hospital-Acquired Conditions 18.3 Documentation, Legal Concepts & Confidentiality
20 Chapter 19: Ethics, Adherence, Epidemiology & Evidence-Based Practice
19.1 Clinical Ethics, Informed Consent & Palliative Wound Management 19.2 Patient Adherence & Psychosocial Care 19.3 Epidemiology of Chronic Wounds 19.4 Research Literacy, Evidence-Based Medicine & Quality Improvement
5.2 Risk Assessment Tools & Risk Stratification
Key Takeaways Explain This Topic AI
The Braden Scale scores six subscales (sensory perception, moisture, activity, mobility, nutrition, and friction and shear) for a total of 6 to 23; lower scores mean higher risk, with common bands of 15–18 mild, 13–14 moderate, 10–12 high, and 9 or less very high risk.
A risk score supplements clinical judgment rather than replacing it; guidelines recommend a structured risk assessment that also considers skin status, perfusion, diabetes, medical devices, and prior pressure injury.
The IWGDF 2023 guidance stratifies diabetic foot ulcer risk: 0 (no loss of protective sensation or PAD, screen yearly), 1 (LOPS or PAD, every 6 to 12 months), 2 (LOPS plus PAD, or either plus foot deformity, every 3 to 6 months), and 3 (LOPS or PAD plus prior ulcer, amputation, or end-stage renal disease, every 1 to 3 months).
Children need pediatric tools: the Braden QD adds items for tissue perfusion and oxygenation, number of medical devices, and repositionability, reflecting how often pediatric pressure injuries are device-related.
Prognostic risk factors for delayed healing include larger wound area, longer wound duration, deeper tissue involvement, ischemia, infection, poor glycemic control, smoking, malnutrition, and nonadherence to offloading or compression.
Last updated: September 2026
5.2 Risk Assessment Tools & Risk Stratification
Core Clinical Principle: Risk assessment finds the patients most likely to develop a wound or fail to heal, so prevention resources go where they matter. Validated scales add structure and consistency, but each score must be paired with a skin inspection, clinical judgment, and a prevention plan that addresses every low subscale.
The CWSP outline lists risk assessment in the Assessment and Diagnosis domain, and identifying patient risk factors and prescribing preventive measures are listed tasks. Expect questions that ask you to score a scale, interpret the result, and choose a matching intervention.
The Braden Scale for Pressure Injury Risk
- Subscale Score Range What a Low Score Means Matching Intervention
- Sensory perception 1–4 Cannot feel or report discomfort Scheduled repositioning, frequent skin checks
Moisture 1–4 Skin constantly moist from incontinence, sweat, or drainage Continence care, barrier products, moisture-wicking linens
- Activity 1–4 Bedfast or chairfast Pressure redistribution surfaces, mobilization plan
- Mobility 1–4 Cannot change position independently Turning schedule, lateral tilt, heel offloading
- Nutrition 1–4 Poor intake Dietitian referral, supplements
Friction and shear 1–3 Slides down in bed, needs full assistance to move Lift sheets, head of bed at 30 degrees or less when possible, trapeze, silicone foam dressings
Totals range from 6 to 23 . Commonly used bands are 15–18 mild (at risk) , 13–14 moderate , 10–12 high , and 9 or less very high risk. Many facilities use 18 as the at-risk threshold for older adults or people with darker skin tones, where early injury is harder to see.
Worked example: A patient who responds only to painful stimuli (sensory 2), is often moist (moisture 2), is chairfast (activity 2), is very limited in mobility (mobility 2), has adequate intake (nutrition 3), and slides down in bed (friction and shear 1) scores 2 + 2 + 2 + 2 + 3 + 1 = 12, high risk .
Other Pressure Injury Scales
Scale Items Direction At-Risk Threshold
Norton Physical condition, mental condition, activity, mobility, incontinence (each 1–4) Lower = higher risk 14 or less
Waterlow Build and weight, skin type, sex and age, continence, mobility, appetite, special risks Higher = higher risk 10 or more at risk; 15 or more high; 20 or more very high
Braden QD Mobility, sensory perception, friction and shear, nutrition, tissue perfusion and oxygenation, number of medical devices, repositionability and skin protection Higher = higher risk 13 or more indicates risk; validated from preterm infants to 21 years in acute care
Scales predict risk only moderately well, and structured risk assessment has not been shown to reduce pressure injury incidence by itself. The international pressure injury guideline therefore recommends a comprehensive risk assessment that includes the scale plus skin and tissue inspection, perfusion, diabetes, medical devices, previous pressure injuries, body temperature, and the patient's general condition, repeated on admission, after any significant change, and at regular intervals.
Diabetic Foot Risk Stratification
The International Working Group on the Diabetic Foot (IWGDF) 2023 guidelines use loss of protective sensation (LOPS), peripheral artery disease (PAD), foot deformity, and history to set screening intervals:
- IWGDF Risk Category Characteristics Screening Frequency
- 0 – Very low No LOPS and no PAD Once a year
- 1 – Low LOPS or PAD Every 6 to 12 months
- 2 – Moderate LOPS + PAD, or LOPS + foot deformity, or PAD + foot deformity Every 3 to 6 months
3 – High LOPS or PAD plus one or more of: history of foot ulcer, lower-extremity amputation (minor or major), or end-stage renal disease Every 1 to 3 months
High-risk patients benefit from therapeutic footwear that reduces plantar pressure, structured education, treatment of pre-ulcerative lesions (callus, blisters, fissures), and, for selected patients, at-home foot temperature monitoring to detect inflammation before an ulcer forms.
Risk Factors for Delayed Healing and Recurrence
- Category Examples
- Wound factors Larger area, longer duration, greater depth, exposed bone or tendon, necrotic tissue, infection
- Perfusion PAD, low toe pressure or TcPO2, smoking, edema
Host factors Diabetes with poor glycemic control, kidney failure, malnutrition, immunosuppression, older age, obesity
Mechanical and behavioral Unrelieved pressure, nonadherence to offloading or compression, limited mobility, poor footwear
Social Low health literacy, food or housing insecurity, lack of transportation or caregiver support
For venous leg ulcers, larger area and longer duration at first visit consistently predict slower healing. For diabetic foot ulcers, depth (probe to bone), ischemia, and infection predict amputation, which is why the WIfI and SINBAD systems combine them. After healing, recurrence risk is high : about 40% of diabetic foot ulcers recur within a year, so a healed foot is "in remission," not cured.
Turning Scores Into Plans
Score the scale and inspect the skin at the same visit.
Address each low subscale with a specific action, not just the total.
Document the score, the plan, and the date of reassessment.
Reassess after surgery, transfer, a change in condition, or a new device.
- Clinical Traps
- Trap 1: A "Safe" Total With a Dangerous Subscale
A Braden total of 17 can hide a friction and shear score of 1 or a sensory score of 1. Target the subscale that is low.
Trap 2: Using Adult Tools for Infants
Adult scales miss device-related risk and the large, heavy head of an infant. Use a pediatric tool such as the Braden QD.